Jane Street Group, LLC Mannkind Corp Call Options Transaction History

Jane Street Group, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $6.7 $64,128 - $85,760	12,800 New	12,800 $80,000
Q1 2022 May 17, 2022	SELL	$2.62 - $4.45 $252,044 - $428,090	-96,200 Reduced 68.52%	44,200 $163,000
Q4 2021 Feb 15, 2022	SELL	$4.05 - $5.37 $227,205 - $301,257	-56,100 Reduced 28.55%	140,400 $614,000
Q3 2021 Nov 16, 2021	SELL	$3.89 - $5.48 $233,011 - $328,252	-59,900 Reduced 23.36%	196,500 $855,000
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.45 $262,447 - $396,215	72,700 Added 39.58%	256,400 $1.4 Million
Q1 2021 May 18, 2021	BUY	$3.14 - $6.14 $262,818 - $513,918	83,700 Added 83.7%	183,700 $720,000
Q1 2019 May 16, 2019	BUY	$1.14 - $2.25 $113,999 - $225,000	100,000 New	100,000 $197,000
Q2 2018 Aug 15, 2018	SELL	$1.59 - $2.38 $30,528 - $45,696	-19,200 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.28 - $3.8 $43,775 - $72,960	19,200 New	19,200 $44,000
Q4 2017 Feb 15, 2018	SELL	$2.28 - $6.71 $557,460 - $1.64 Million	-244,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.15 - $2.29 $281,175 - $559,905	244,500	244,500 $531,000

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.81B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.